Screening/Prevention Rectal Cancer

EPI proColon® – Novel Blood Screening Test Approved for Colorectal Cancer Detection (05-2-2016)

The United States Food and Drug Administration (FDA) has approved Epi proColon®, a test that screens for colorectal cancer from a simple blood draw. The approval specifies that EPI proColon is only indicated for individuals at an average risk of developing... Continue Reading

Anesthesia Increases Colonoscopy Risks (03-4-2016)

Though colonoscopy is often performed with anesthesia, a recent study published in the journal Gastroenterology has found that sedation increases the risk of complications.1 A colonoscopy is a type of exam that a doctor uses to check the lining of the... Continue Reading

Does Processed Meat Cause Colorectal Cancer? (11-16-2015)

According to the International Agency for Research on Cancer (IARC), eating processed meat products can increase a person’s risk for developing colorectal cancer. Processed meat is classified as meat that has been salted, cured, fermented, or smoked... Continue Reading

Cancers Caught During Screening Colonoscopy are More Survivable (07-21-2015)

Patients whose colorectal cancer (CRC) is detected during a screening colonoscopy are likely to survive longer than those who wait until they have symptoms before having the test, according to a study in the July issue of GIE: Gastrointestinal Endoscopy,... Continue Reading

Stool Test Spots Most Colon Cancers (02-19-2014)

A stool test known as the fecal immunochemical test (FIT) is accurate in diagnosing most colorectal cancers, according to a meta-analysis published in the Annals of Internal Medicine. Screening is crucial for the prevention and early detection of colorectal... Continue Reading

Colorectal Cancer Screening Works Over Long-Term (10-4-2013)

The results of a study published in the New England Journal of Medicine, suggest that it pays to follow colorectal cancer screening recommendations—and people who do follow the guidelines are less likely to develop colon cancer than people who do not. Colorectal... Continue Reading

Low-Dose Aspirin Reduces Colon Cancer Risk in Women (08-7-2013)

Women who take a low-dose aspirin every other day have a reduced risk of colon cancer, according to the results of a study published in the Annals of Internal Medicine—however, the benefit carries with it a risk of gastrointestinal bleeding.[1] Colorectal... Continue Reading

Biomarker Could Potentially Help Detect Colorectal Cancer (07-29-2013)

Blood levels of miR-21, a piece of DNA known as microRNA, could serve as a promising biomarker for the early detection and prognosis of colorectal cancer, according to the results of a study published in the Journal of the National Cancer Institute. Colorectal... Continue Reading

Aspirin’s Preventive Effect for Colorectal Cancer Linked to Genotype (07-24-2013)

Aspirin’s preventive effect for colorectal cancer may be limited to tumors without a genetic mutation known as BRAF, according to the results of a study published in the Journal of the American Medical Association.[1] Colorectal cancer remains the... Continue Reading

Aspirin May Prolong Life in PIK3CA-Mutated Colorectal Cancers (11-6-2012)

Daily aspirin use improves survival among patients with mutated-PIK3CA colorectal cancer, according to the results of a study published in the New England Journal of Medicine. Colorectal cancer remains the second leading cause of cancer-related death... Continue Reading

Next Page »